Lobbying

Adma Biologics ADMA's latest lobbying report covers Q2 2026, at $10K. The four quarters Q3 2025–Q2 2026 total $20K. Its first report covers Q4 2022; the issues it reports most are Defense and Health Issues.

Adma BiologicsADMA

Adma Biologics stock page

Latest quarter
$10K
Q2 2026 · 1 reports
Last 12 months
$20K
Last 4 quarters
vs last quarter
No record
Q2 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

Adma Biologics lobbying by quarter
Adma Biologics lobbying by quarter
QuarterAmountReports
Q4 2022$10K1
Q1 2023$10K1
Q2 2023$10K1
Q3 2023$10K1
Q4 2023$01
Q1 2024$10K1
Q2 2024$01
Q3 2024$01
Q4 2024$01
Q1 2025$01
Q2 2025$01
Q3 2025$10K1
Q4 2025$01
Q1 2026$01
Q2 2026$10K1

Policy issues the reports name

  • Defense6 reports
  • Health issues4 reports

A report that names several issues counts once for each.

Who was lobbied

  • HOUSE OF REPRESENTATIVES10 reports
  • SENATE2 reports

Firms it paid

Firm
American Defense International$70K15 quarters

Former officials lobbying for it

No lobbyist with a covered position.

Lobbying reports

Filed by
07/15for Q2American Defense International$10K
04/16for Q1American Defense InternationalUnder $5,000
01/19for Q4 2025American Defense InternationalUnder $5,000
25/10/20for Q3 2025American Defense International$10K
25/07/18for Q2 2025American Defense InternationalUnder $5,000
25/04/17for Q1 2025American Defense InternationalUnder $5,000
25/01/17for Q4 2024American Defense InternationalUnder $5,000
24/10/17for Q3 2024American Defense InternationalUnder $5,000
24/07/17for Q2 2024American Defense InternationalUnder $5,000
24/04/17for Q1 2024American Defense International$10K
24/01/16for Q4 2023American Defense InternationalUnder $5,000
23/10/20for Q3 2023American Defense International$10K
23/07/19for Q2 2023American Defense International$10K
23/04/17for Q1 2023American Defense International$10K
23/01/18for Q4 2022American Defense International$10K